Technical Analysis for ACET - Adicet Bio, Inc.

Grade Last Price % Change Price Change
F 5.89 1.73% 0.10
ACET closed up 1.73 percent on Friday, March 24, 2023, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 1.73%
Lower Bollinger Band Walk Weakness 1.73%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 10 hours ago
Possible Inside Day about 10 hours ago
Up 2% about 12 hours ago
60 Minute Opening Range Breakout about 13 hours ago
Up 1% about 13 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Disease Immune System Antibodies Cancer Immunotherapy Chimeric Antigen Receptor T Cell Therapies For Cancer Chimeric Antigen Receptor T Cell Immune Response Adoptive Cell Transfer Antigen

Is ACET a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 21.87
52 Week Low 5.64
Average Volume 536,126
200-Day Moving Average 13.28
50-Day Moving Average 8.01
20-Day Moving Average 7.28
10-Day Moving Average 6.92
Average True Range 0.54
RSI 30.56
ADX 25.72
+DI 11.32
-DI 34.45
Chandelier Exit (Long, 3 ATRs) 6.59
Chandelier Exit (Short, 3 ATRs) 7.27
Upper Bollinger Bands 8.68
Lower Bollinger Band 5.87
Percent B (%b) 0.01
BandWidth 38.67
MACD Line -0.57
MACD Signal Line -0.42
MACD Histogram -0.1535
Fundamentals Value
Market Cap 115.62 Million
Num Shares 19.6 Million
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.82
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.28
Resistance 3 (R3) 6.26 6.11 6.22
Resistance 2 (R2) 6.11 6.01 6.12 6.19
Resistance 1 (R1) 6.00 5.95 6.06 6.02 6.17
Pivot Point 5.85 5.85 5.88 5.86 5.85
Support 1 (S1) 5.74 5.75 5.80 5.76 5.61
Support 2 (S2) 5.59 5.69 5.60 5.59
Support 3 (S3) 5.48 5.59 5.57
Support 4 (S4) 5.50